Download Bad Blood Secrets and Lies in a Silicon Valley Startup John Carreyrou 9780525431992 Books
The Financial Times McKinsey Business Book of the Year
A New York Times Notable Book
A Washington Post Notable Book
One of the Best Books of the Year NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron—a tale of ambition and hubris set amid the bold promises of Silicon Valley.
Download Bad Blood Secrets and Lies in a Silicon Valley Startup John Carreyrou 9780525431992 Books
"This is an impeccably researched and referenced account of the Theranos saga. As a long-time observer and sometime competitor of Theranos I watched this tale unfold whilst working at a couple of established IVD companies. Everyone I knew who had ever developed an assay or instrument knew this was smoke and mirrors, impossibly too good to be true. What I never suspected was just how personally dishonest EH had been, and for how long the complex deception was maintained. Whilst I've met a few egregious individuals working for big companies, there are enough checks and balances (QA/RA, Med/Sci Affairs, CLSs and other professionals etc) in place to stop harmful devices getting out the door.
The subject matter - developing devices and assays - is a complex dry topic, difficult to write engagingly about. But JC does a workmanlike job and I read this in one go after its midnight Kindle release. My only nit to pick is the poor editing: there are so many uses of '....named....' as in 'an engineer named John Smith' or 'a restaurant named Joe's Bar' that it got irritating. Find/replace 'named' with a comma would have worked fine in most cases. The text was also repetitive - eg '...an award named after Channing...' gets at least 2 mentions. But not enough to lose a star.
Kudos to the good people at Theranos who had the courage to get the story out and for JCs persistence into a headwind of legalistic intimidation. I've heard Theranos is now a case-study for MBA students: this book should be required reading for anyone thinking about 'disrupting' the medical devices industry. There are lives at stake."
Product details
|
Tags : Bad Blood Secrets and Lies in a Silicon Valley Startup [John Carreyrou] on . <b>The Financial Times</i> McKinsey Business Book of the Year </b> <b> A New York Times</i> Notable Book</b> <b> A Washington Post</i> Notable Book </b> <b> One of the Best Books of the Year NPR,John Carreyrou,Bad Blood Secrets and Lies in a Silicon Valley Startup,Vintage,0525431993,BUSINESS ECONOMICS / Corporate Finance / Venture Capital,BUSINESS ECONOMICS / Entrepreneurship,Business Economics/Corporate Finance - Venture Capital,Business Economics/Finance - General,Business Economics/Infrastructure,Business/Economics,GENERAL,General Adult,HISTORY OF SPECIFIC COMPANIES,Non-Fiction,TECHNOLOGY ENGINEERING / Biomedical,Technology Engineering/Biomedical,United States,WHITE COLLAR CRIME,his and hers gifts;non fiction books best sellers;best sellers list new york times 2019;technology gifts;best sellers on ;inventor;the inventor out for blood;the inventor;true crime books;books best sellers;nonfiction books;new york times best sellers;finance books;true crime;business books;non fiction books;start up;silicon valley;technology books;biomedical engineering;best history books;new york best seller list;biotechnology;nonfiction;great on kindle books;venture capital;non fiction,venture capital; top books 2018 best seller; new york time best sellers; nonfiction books; top rated books; bestselling book; non fiction best sellers list; best sellers list new york times 2018; best sellers list new york times; new york times best sellers; finance books; true crime; business books; books best sellers; nonfiction best sellers 2018; best books of 2018; best books 2018; best books on ; best books; medical books; theranos; true crime books; the inventor out for blood; the inventor; books
Bad Blood Secrets and Lies in a Silicon Valley Startup John Carreyrou 9780525431992 Books Reviews :
Bad Blood Secrets and Lies in a Silicon Valley Startup John Carreyrou 9780525431992 Books Reviews
- This is an impeccably researched and referenced account of the Theranos saga. As a long-time observer and sometime competitor of Theranos I watched this tale unfold whilst working at a couple of established IVD companies. Everyone I knew who had ever developed an assay or instrument knew this was smoke and mirrors, impossibly too good to be true. What I never suspected was just how personally dishonest EH had been, and for how long the complex deception was maintained. Whilst I've met a few egregious individuals working for big companies, there are enough checks and balances (QA/RA, Med/Sci Affairs, CLSs and other professionals etc) in place to stop harmful devices getting out the door.
The subject matter - developing devices and assays - is a complex dry topic, difficult to write engagingly about. But JC does a workmanlike job and I read this in one go after its midnight release. My only nit to pick is the poor editing there are so many uses of '....named....' as in 'an engineer named John Smith' or 'a restaurant named Joe's Bar' that it got irritating. Find/replace 'named' with a comma would have worked fine in most cases. The text was also repetitive - eg '...an award named after Channing...' gets at least 2 mentions. But not enough to lose a star.
Kudos to the good people at Theranos who had the courage to get the story out and for JCs persistence into a headwind of legalistic intimidation. I've heard Theranos is now a case-study for MBA students this book should be required reading for anyone thinking about 'disrupting' the medical devices industry. There are lives at stake. - I started this book and could not put it down. It's a horrifying true story of a driven entrepreneur whose only overriding goal was to become insanely rich. And she would do anything, any unimagineable thing, to get there.
Elizabeth Holmes leveraged her family's high profile connections to draw in early investors and supporters, who were not very inquisitive on details, nor very skeptical in nature. Drawing on the good name and reputation of these early supporters, she was able to build an impressive roster of other supporters with stellar reputations in tech and venture capital circles. From there, it was just a matter of stage managing the house of cards she was building.
Holmes crafted a Potemkin village that had fooled investors, customers, and visiting dignitaries. Her product demonstrations were outright theater, staged managed illusions worthy of David Copperfield. Theranos employees in on the ruse were assured it was just temporary, until the actual product could be perfected and the results repeatable. That day would never come. Those on the outside who also worked in this field had well founded and grave doubts about how Theranos could be touting a product that seemingly defied both logic and physics. Their suspicions, proven to be correct, was that it was too good to be true.
Without a trace of guilt or regret, she induced powerful tech workers to leave lucrative careers at other major tech firms, giving up millions in stock options, to come work for Theranos, surely knowing the whole thing would collapse one day. When skeptical board members asked to see data affirming the effectiveness of their product, Holmes would defer, saying those papers were in perpetual legal review. Some employees, when they were no longer useful to her, or deemed disloyal, were immediately and unceremoniously marched out.
This is a real life thriller, the story of someone who is a true diabolical movie villain. Holmes is portrayed vividly as a paranoid sociopath who could also be disarming, charmingly manipulative, utterly ruthless and devoid of conscience. This is a tale of corporate greed and lack of regulatory oversight gone all awry. - It takes a mighty strong person and an incredible investigative journalist to take down a multibillion company lead by a CEO and her partner who are doing nothing but telling lies, mistreating their employees, taking millions of dollars under false pretenses from Fortune 500 businesses and wealthy investors, betraying their esteemed board members, and worst and most harmful of all, putting the lives of their end customers in serious jeopardy because the technology that they claim to have engineered does not exist nor has it been FDA approved or tested. This is John Carreyrou’s BAD BLOOD SECRETS AND LIES IN A SILICON VALLEY STARTUP. Carreyrou went to monumental lengths over the course of several years, with the help of named and unnamed sources who worked or were connected to Theranos, the company, which claimed to have created a blood-testing device that with ‘one drop of blood’ could obtain hundreds of test results thus saving lives. Not only were their little machines ineffective but they were doing no such thing. Meaning, they could not provide accurate test results because they were not even obtaining them. Rather, they were using commercial analyzers in their place. At the helm was Theranos founder and CEO Elizabeth Holmes, a Stanford drop-out who had a brilliant idea, but it was never brought to fruition. She simply leads people to believe it was with her charm. A lot of people.
It is staggering how many people she swayed. We’re not just talking about a co-worker or two but former heads of state, who later joined her board, people who amassed fortunes in the billions who were willing to loan Theranos money, major corporations including Walgreens and Safeway who wanted to get in on the ground floor, and many more. It is equally astonishing how so many smart, successful people were not taken aback by her freakish obsession with imitating Steve Jobs. Perhaps, they chalked this up to her eccentricity.
It took courage for people to come forward. They were threatened with lawsuits that could bankrupt them ten times over, by one of the leading and most intimidating litigators in the country. Carreyrou, a Pulitzer Prize winning investigative journalist, who has been with The Wall Street Journal for almost 10 years, had the support of his editor, newspaper, and its attorneys. He never thought for a minute to back down. The result – a series of articles in the paper that exposed Theranos and Holmes for the fraud they committed.
It is dumbfounding to read BAD BLOOD and to think that Holmes and her number two in command, Sunny Balwani, also her romantic partner, which was kept secret, got away with so much for so long, and even when finally confronted and their hands were forced, they still would not admit fault. Is Holmes a criminal? Is she delusional?
What I do know is that you will not be able to put this book down.